Works matching AU Mahipal, Amit
Results: 82
Long-term Survival in Patients with Advanced Hepatocellular Cancer with Dual Immunotherapy Agents: Tremelimumab Plus Durvalumab.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 1, p. 2, doi. 10.17925/ohr.2024.20.1.1
- By:
- Publication type:
- Article
Durvalumab: A PD-L1 Blocking Antibody for the Treatment of Adult Patients with Locally Advanced or Metastatic Biliary Tract Cancer.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 22, doi. 10.17925/OHR.2023.19.1.22
- By:
- Publication type:
- Article
Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETs): Case Report.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1197288
- By:
- Publication type:
- Article
First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 7, p. 1211, doi. 10.1007/s00262-019-02331-x
- By:
- Publication type:
- Article
Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 1039, doi. 10.1007/s00262-011-1019-1
- By:
- Publication type:
- Article
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study.
- Published in:
- Journal of Immunotherapy & Precision Oncology, 2025, v. 8, n. 1, p. 71, doi. 10.36401/JIPO-24-8
- By:
- Publication type:
- Article
Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.651119
- By:
- Publication type:
- Article
Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinoma.
- Published in:
- Medical Oncology, 2012, v. 29, n. 1, p. 134, doi. 10.1007/s12032-010-9802-y
- By:
- Publication type:
- Article
First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 10463, doi. 10.2147/CMAR.S208720
- By:
- Publication type:
- Article
Novel and emerging targets for cholangiocarcinoma progression: therapeutic implications.
- Published in:
- Expert Opinion on Therapeutic Targets, 2022, v. 26, n. 1, p. 79, doi. 10.1080/14728222.2022.2029412
- By:
- Publication type:
- Article
Rho GTPase effectors and NAD metabolism in cancer immune suppression.
- Published in:
- Expert Opinion on Therapeutic Targets, 2018, v. 22, n. 1, p. 9, doi. 10.1080/14728222.2018.1413091
- By:
- Publication type:
- Article
Effect of Age on Clinical Outcomes in Phase 1 Trial Participants.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2015, v. 22, n. 2, p. 235, doi. 10.1177/107327481502200217
- By:
- Publication type:
- Article
Toxicity Associated with Pembrolizumab Monotherapy in Patients with Gastrointestinal Cancers: A Systematic Review of Clinical Trials.
- Published in:
- Biomedicines, 2025, v. 13, n. 1, p. 229, doi. 10.3390/biomedicines13010229
- By:
- Publication type:
- Article
First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations.
- Published in:
- Digestive Diseases & Sciences, 2022, v. 67, n. 8, p. 3797, doi. 10.1007/s10620-021-07303-9
- By:
- Publication type:
- Article
Pharmacokinetics and safety of vitamin E δ-tocotrienol after single and multiple doses in healthy subjects with measurement of vitamin E metabolites.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 481, doi. 10.1007/s00280-015-2814-8
- By:
- Publication type:
- Article
Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody targeting the DR5 receptor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 887, doi. 10.1007/s00280-015-2712-0
- By:
- Publication type:
- Article
Targeted Therapies in Advanced Cholangiocarcinoma.
- Published in:
- Life (2075-1729), 2023, v. 13, n. 10, p. 2066, doi. 10.3390/life13102066
- By:
- Publication type:
- Article
FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 2968, doi. 10.3390/cancers13122968
- By:
- Publication type:
- Article
Aspirin and Statin Use and the Risk of Gallbladder Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1186, doi. 10.3390/cancers13051186
- By:
- Publication type:
- Article
Research Progress of Biliary Tract Cancers.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2808, doi. 10.3390/cancers12102808
- By:
- Publication type:
- Article
Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2039, doi. 10.3390/cancers12082039
- By:
- Publication type:
- Article
Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1078, doi. 10.3390/cancers11081078
- By:
- Publication type:
- Article
Contemporary Management of Localized Resectable Pancreatic Cancer.
- Published in:
- Cancers, 2018, v. 10, n. 1, p. 24, doi. 10.3390/cancers10010024
- By:
- Publication type:
- Article
A case of acquired hemophilia associated with bullous pemphigoid.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 6, p. 502, doi. 10.1002/ajh.20890
- By:
- Publication type:
- Article
Atezolizumab plus bevacizumab as first-line systemic therapy for hepatocellular carcinoma: a multi-institutional cohort study.
- Published in:
- Oncologist, 2024, v. 29, n. 11, p. 986, doi. 10.1093/oncolo/oyae142
- By:
- Publication type:
- Article
Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 917, doi. 10.1093/oncolo/oyad144
- By:
- Publication type:
- Article
Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 510, doi. 10.1093/oncolo/oyad009
- By:
- Publication type:
- Article
EGFR Inhibitors in Patients with Advanced Squamous Cell Anal Carcinomas: A Single-Institution Experience.
- Published in:
- Oncology, 2017, v. 92, n. 4, p. 190, doi. 10.1159/000452766
- By:
- Publication type:
- Article
Carboplatin and Paclitaxel Treatment Is Effective in Advanced Anal Cancer.
- Published in:
- Oncology, 2014, v. 87, n. 2, p. 125, doi. 10.1159/000361051
- By:
- Publication type:
- Article
Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Biomarkers for Pancreatic Cancer: Is it Ready for Primetime?
- Published in:
- JOP Journal of the Pancreas, 2013, v. 14, n. 4, p. 309
- By:
- Publication type:
- Article
Paradoxical effect of capecitabine in 5-fluorouracil-induced cardiotoxicity: A case vignette and literature review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 3, p. 552, doi. 10.1177/1078155215579303
- By:
- Publication type:
- Article
Fatal Pulmonary Toxicity After a Single Dose of Cyclophosphamide.
- Published in:
- Pharmacotherapy, 2007, v. 27, n. 4, p. 616, doi. 10.1592/phco.27.4.616
- By:
- Publication type:
- Article
A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 134, doi. 10.1007/s10637-021-01170-x
- By:
- Publication type:
- Article
Phase IB study of sorafenib and evofosfamide in patients with advanced hepatocellular and renal cell carcinomas (NCCTG N1135, Alliance).
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1072, doi. 10.1007/s10637-021-01090-w
- By:
- Publication type:
- Article
Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 473, doi. 10.1007/s10637-018-0676-8
- By:
- Publication type:
- Article
Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignancies.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1093, doi. 10.1007/s10637-015-0277-8
- By:
- Publication type:
- Article
Evaluating the Therapeutic Potential of Durvalumab in Adults with Locally Advanced or Metastatic Biliary Tract Cancer: Evidence to Date.
- Published in:
- OncoTargets & Therapy, 2024, v. 17, p. 383, doi. 10.2147/OTT.S391707
- By:
- Publication type:
- Article
Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 5145, doi. 10.2147/OTT.S272208
- By:
- Publication type:
- Article
Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 10335, doi. 10.2147/OTT.S214870
- By:
- Publication type:
- Article
Effect of Metformin Use on Survival in Resectable Pancreatic Cancer: A Single-Institution Experience and Review of the Literature.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0151632
- By:
- Publication type:
- Article
Novel targeted treatment options for advanced cholangiocarcinoma.
- Published in:
- Expert Opinion on Investigational Drugs, 2018, v. 27, n. 9, p. 709, doi. 10.1080/13543784.2018.1512581
- By:
- Publication type:
- Article
Metabolism, toxicity and management of fruquintinib: a novel drug for metastatic colorectal cancer.
- Published in:
- Expert Opinion on Drug Metabolism & Toxicology, 2024, v. 20, n. 4, p. 197, doi. 10.1080/17425255.2024.2332364
- By:
- Publication type:
- Article
Fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma: current status, insight on resistance mechanisms and toxicity management.
- Published in:
- Expert Opinion on Drug Metabolism & Toxicology, 2022, v. 18, n. 1, p. 85, doi. 10.1080/17425255.2022.2039118
- By:
- Publication type:
- Article
Pemigatinib in cholangiocarcinoma with a FGFR2 rearrangement or fusion.
- Published in:
- Expert Review of Anticancer Therapy, 2022, v. 22, n. 12, p. 1265, doi. 10.1080/14737140.2022.2150168
- By:
- Publication type:
- Article
The efficacy, safety, and predictors of outcomes of transarterial radioembolization for hepatocellular carcinoma: a retrospective study.
- Published in:
- Expert Review of Gastroenterology & Hepatology, 2020, v. 14, n. 7, p. 619, doi. 10.1080/17474124.2020.1777856
- By:
- Publication type:
- Article